Print

Ad26 or Ad28 prime boosted with rLCMV

rAd prime/rLCMV boost regimen induces long-lasting HIV-1-spcific humoral and cellular immune responses in mice.

Trial Details:

Ongoing
Ad26 & Ad28 HIV-1 gp140B , replication-deficient lymphocytic choriomeningitis virus
Ad26 & Ad28 HIV-1 gp140B Viral Vector - Adeno
replication-deficient lymphocytic choriomeningitis virus